Abstract
Hepatitis C virus (HCV) is known to be responsible for both hepatic and extrahepatic diseases. Among systemic HCV-related extrahepatic diseases (HCV-EHDs), mixed cryoglobulinemia (MC) has been extensively studied. More recently, an increased prevalence of endocrine disorders has been observed in a large series of HCV-infected patients with MC. The most frequent and clinically important endocrine disorders in MC are thyroid disorders and type 2 diabetes mellitus (T2D). A significant association between MC and thyroid autoimmunity and hypothyroidism has been shown. A high prevalence of thyroid cancer has also been reported. Furthermore, several clinical epidemiologic studies demonstrated that MC is associated to T2D. An increasing number of studies have linked a Th1 immune response with HCV infection, MC, autoimmune thyroid disorders, and diabetes. These data suggest a common immunological Th1 pattern as the pathophysiological basis of the association.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferri C, Antonelli A, Mascia MT et al (2007) B-cells and mixed cryoglobulinemia. Autoimmun Rev 7:114–120
Sansonno D, Carbone A, De Re V et al (2007) Hepatitis C virus infection, cryoglobulinaemia, and beyond. RheumaÂtology (Oxford) 46:572–578
Antonelli A, Ferri C, Galeazzi M et al (2008) HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol 26:S39–S47
Antonelli A, Ferri C, Ferrari SM et al (2008) ImmunoÂpathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 8:18–23
Antonelli A, Ferri C, Fallahi P et al (2006) Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16:563–572
Antonelli A, Ferri C, Pampana A et al (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117:10–13
Antonelli A, Ferri C, Fallahi P et al (2004) Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. QJM 97:499–506
Giordano TP, Henderson L, Landgren O et al (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297:2010–2017
Antonelli A, Ferri C, Ferrari SM et al (2009) Endocrine manifestations of hepatitis C virus infection. Nat Clin Pract Endocrinol Metab 5:26–34
Antonelli A, Ferri C, Fallahi P (2009) Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy. Nat Rev Gastroenterol Hepatol 6:633–635
Gowans EJ (2000) Distribution of markers of hepatitis C virus infection throughout the body. Semin Liver Dis 20:85–102
Bartolomé J, RodrÃguez-Iñigo E, Quadros P et al (2008) Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 80:1588–1594
Prummel MF, Laurberg P (2003) Interferon-alpha and autoimmune thyroid disease. Thyroid 13:547–551
Apolinario A, Majano PL, Lorente R et al (2005) Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 12:27–37
Antonelli A, Rotondi M, Fallahi P et al (2004) High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89:5496–5499
Antonelli A, Rotondi M, Fallahi P et al (2005) Increase of interferon-gamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152:171–177
Antonelli A, Rotondi M, Ferrari SM et al (2006) Interferon-gamma-inducible alpha-chemokine CXCL10 involvement in Graves’ ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 9:614–620
Antonelli A, Ferri C, Fallahi P et al (2008) High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. Cytokine 42:137–143
Antonelli A, Ferri C, Fallahi P et al (2008) Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. Metabolism 57:1270–1277
Antonelli A, Ferri C, Fallahi P (1999) Thyroid cancer in patients with hepatitis C infection. JAMA 281:1588
Antonelli A, Ferri C, Fallahi P et al (2002) Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin Exp Rheumatol 20:693–696
Antonelli A, Ferri C, Fallahi P et al (2007) Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. Thyroid 17:447–451
Okayasu I, Fujiwara M, Hara Y et al (1995) Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma: a study of surgical cases among Japanese, and white and African Americans. Cancer 76:2313–2318
Noto H, Raskin P (2006) Hepatitis C infection and diabetes. J Diabetes Complications 20:113–120
Antonelli A, Ferri C, Fallahi P et al (2005) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28:2548–2550
Antonelli A, Ferri C, Fallahi P et al (2004) Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. Rheumatology (Oxford) 43:238–240
Mehta SH, Brancati FL, Sulkowski MS et al (2000) Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 133:592–599
Mehta SH, Brancati FL, Strathdee SA et al (2003) Hepatitis C virus infection and incident type 2 diabetes. Hepatology 38:50–56
Tanaka H, Shiota G, Kawasaki H (1997) Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C. J Med 28:335–346
Giordanino C, Bugianesi E, Smedile A et al (2008) Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis c infection by response to treatment: results of a cohort study. Am J Gastroenterol 103:2481–2487
Masini M, Campani D, Boggi U et al (2005) Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 28:940–941
Skowronski M, Zozulinska D, Juszczyk J et al (2006) Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 29:750
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Italia
About this chapter
Cite this chapter
Antonelli, A. et al. (2012). Endocrine Manifestations of HCV-Positive Cryoglobulinemia. In: Dammacco, F. (eds) HCV Infection and Cryoglobulinemia. Springer, Milano. https://doi.org/10.1007/978-88-470-1705-4_24
Download citation
DOI: https://doi.org/10.1007/978-88-470-1705-4_24
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1704-7
Online ISBN: 978-88-470-1705-4
eBook Packages: MedicineMedicine (R0)